Cardiovascular Effects of CAR T Cell Therapy | JACC ...
Background AntiCD19 chimeric antigen receptor (CAR) T cell therapy holds great promise in the treatment of patients with hematologic malignancies. A high occurrence of cardiac dysfunction has been noted in children treated with CAR T cell therapy. Objectives The aim of this study was to define the occurrence of major adverse cardiovascular .